Related references
Note: Only part of the references are listed.Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study
Nina Grytten et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Peter Alping et al.
ANNALS OF NEUROLOGY (2020)
Socioeconomic status and multiple sclerosis outcome
Jan Hillert
NATURE REVIEWS NEUROLOGY (2020)
Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
Esther Melamed et al.
FRONTIERS IN IMMUNOLOGY (2020)
Multiple sclerosis and cancer incidence: A Danish nationwide cohort study
M. Norgaard et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort
Emanuele D'Amico et al.
FRONTIERS IN NEUROLOGY (2019)
Risk of cancer among Finnish multiple sclerosis patients
Kira Hongell et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs
Christine Lebrun et al.
CNS DRUGS (2018)
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study
Kjetil Bjornevik et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study
Kjetil Bjornevik et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
Hanne Marie Boe Lunde et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Alemtuzumab CARE-MS II 5-year follow-up
Alasdair J. Coles et al.
NEUROLOGY (2017)
Cancer co-occurrence patterns in Parkinson's disease and multiple sclerosis-Do they mirror immune system imbalances?
Vladeta Ajdacic-Gross et al.
CANCER EPIDEMIOLOGY (2016)
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker et al.
NATURE REVIEWS CANCER (2016)
Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells
Ou Huang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Increased breast cancer risk for patients with multiple sclerosis: a nationwide population-based cohort study
L. -M. Sun et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Month of birth and risk of multiple sclerosis: confounding and adjustments
Oivind Torkildsen et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway
Margitta T. Kampman et al.
JOURNAL OF NEUROLOGY (2013)
New insights into the synergism of nucleoside analogs with radiotherapy
Michael W. Lee et al.
RADIATION ONCOLOGY (2013)
Cancer risk in multiple sclerosis: findings from British Columbia, Canada
Elaine Kingwell et al.
BRAIN (2012)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
CANCER RISK AMONG PATIENTS WITH MULTIPLE SCLEROSIS AND THEIR PARENTS
Silvia Hofer et al.
NEUROLOGY (2010)
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness
Inger Kristin Larsen et al.
EUROPEAN JOURNAL OF CANCER (2009)
Cancer risk among patients with multiple sclerosis and their parents
S. Bahmanyar et al.
NEUROLOGY (2009)
Downregulating sphingosine kinase-1 for cancer therapy
Olivier Cuvillier
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
FDA drug approval summary: Alemtuzumab as single-agent treatment for B-Cell chronic lymphocytic leukemia
Suzanne Demko et al.
ONCOLOGIST (2008)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cancer risk among patients with multiple sclerosis: A population-based register study
NM Nielsen et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Anti-α4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis
Y Mori et al.
BLOOD (2004)
Smoking is a risk factor for multiple sclerosis
T Riise et al.
NEUROLOGY (2003)
Mobility impairments and use of preventive services in women with multiple sclerosis: observational study
E Cheng et al.
BRITISH MEDICAL JOURNAL (2001)
Share Paper
